THE FUTURE OF PERSONALIZED MEDICINE IN LOW- INCOME COUNTRIES
DOI:
https://doi.org/10.53350/Annalspakmed.1.1.1Keywords:
Early diagnosis, Cancer burden, Screening programs, Diagnostic capacity, Public awarenessAbstract
In recent decades, the landscape of global healthcare has been rapidly transformed by the emergence of personalized medicine an approach that tailor’s diagnosis, prevention, and treatment to the individual’s genetic, environmental, and lifestyle factors1. In high-income nations, this model is already reshaping clinical practice, especially in fields like oncology, cardiology, and rare genetic disorders. Yet for low-income countries (LICs), where health systems are often constrained by limited resources, infrastructure gaps, and competing health priorities, the promise of personalized medicine remains distant. The critical question today is not whether personalized medicine can reach these regions, but how it can be made accessible, equitable, and sustainable2.
References
1. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793-795. doi:10.1056/NEJMp1500523.
2. Ashley EA. The precision medicine initiative: a new national effort. JAMA. 2015;313(21):2119-2120.
3. Abubakar A, Malik M, Manzoor I, Alotaibi MS, Mirdamadi S. Challenges and opportunities for implementing personalized medicine in low and middle-income countries. Front Genet. 2021;12:619872. doi:10.3389/fgene.2021.619872
4. Rotimi C, Jorde LB. Ancestry and disease in the age of genomic medicine. N Engl J Med. 2010;363(16):1551-1558.
5. Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177(1):26-31. doi:10.1016/j.cell.2019.02.048
6. McMahon FJ. Pharmacogenetics in low- and middle-income countries: opportunities and challenges. Pharmacogenomics J. 2019;19(6):479-487. doi:10.1038/s41397-019-0074-5
7. Tekola-Ayele F, Rotimi CN. Translational genomics in low- and middle-income countries: Opportunities for precision public health. Genome Med. 2015;7:1-8. doi:10.1186/s13073-015-0195-6
8. Adoga MP, Fatumo SA, Agwale SM. H3Africa: a tipping point for a revolution in bioinformatics, genomics and health research in Africa. Source Code Biol Med. 2014;9:10. doi:10.1186/1751-0473-9-10.
9. Krittanawong C, Johnson KW, Roselli C, Khademi A, Wang Z, Ying X, et al. Artificial intelligence and precision medicine: Opportunities and challenges. Eur Heart J. 2019;40(22):1798-1806. doi:10.1093/eurheartj/ehy564
10. Moodley K, Kleinsmidt A. Ethical issues in genomic research in low-income settings. BMC Med Ethics. 2021;22(1):1-9. doi:10.1186/s12910-021-00650-8
11. World Health Organization. Ethics and governance of artificial intelligence for health. Geneva: WHO; 2021.
12. Dzau VJ, Ginsburg GS. Realizing the full potential of precision medicine in global health. Sci Transl Med. 2016;8(336):336ps11. doi:10.1126/scitranslmed.aaf6852
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 NAVEED SHUJA
This work is licensed under a Creative Commons Attribution 4.0 International License.
